Greater soy consumption associated with lower breast cancer risk in women

Greater soy consumption associated with lower breast cancer risk in women

An article published in the latest issue of the journal Nutrition and Cancer (volume 60, issue 5) revealed the finding of Korean researchers of a protective effect of soy on the risk of developing breast cancer. The study’s conclusion supports that of previous research concerning soy’s effect on breast cancer risk.

Scientists at Hanyang University in Seoul, Korea compared 362 women diagnosed with breast cancer with an equal number of healthy women matched for age and menopausal status. Participants were interviewed concerning their diets, which included tofu, soybean paste, boiled soybeans and soy milk. Total soy protein intake was used as a measure of total soy food consumption.

Compared with women who did not have breast cancer, those who were diagnosed with the disease were likelier to consume more carbohydrates and less likely to drink alcohol or use multivitamin supplements. Women with breast cancer also had fewer children. High soy protein intake was associated with a reduced risk of breast cancer. Among premenopausal women whose intake of soy protein was among the top 20 percent of participants, there was a 61 percent lower adjusted risk of breast cancer compared with those in the lowest 20 percent. For postmenopausal women, the risk experienced by the highest soy protein intake group was 78 percent lower, although the dose-response relationship observed in premenopausal women was not noted in this group. When tofu consumption was separately analyzed, it emerged as protective for premenopausal women only, with those in the top fifth of tofu intake having a 77 percent lower risk of breast cancer than those in the lowest.

Isoflavones contained in soy may effect the development of breast cancer by competing with the body’s own estrogens in binding to estrogen receptors. They may also lower breast cancer risk by increasing sex hormone binding globulin, which reduces blood estrogen levels. Additionally, research suggests that soy isoflavones may inhibit the aromatization of circulating androgens to estrogens in postmenopausal women. Furthermore, there is evidence that soy protein (without isoflavones) can suppress the development of mammary cancer in an animal model. Isoflavones may work in conjunction with soy protein to exert the benefits associated with soy intake.

The researchers recommend their results be interpreted with caution, due to the controversy that exists concerning soy’s possible effects on breast cancer. Nevertheless, the present study’s findings could help support the use of soy as one component of a health-promoting diet. “Our findings, if confirmed, can provide a dietary guideline for the prevention of breast cancer,” the authors conclude.


Post a Comment

All Contents Copyright ©2020 Life Extension® All rights reserved.
Privacy Notice | Terms of Use
These statements have not been evaluated by the Food and Drug Administration.
These products are not intended to diagnose, treat, cure, or prevent any disease.
The information provided on this site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. You should consult with a healthcare professional before starting any diet, exercise or supplementation program, before taking any medication, or if you have or suspect you might have a health problem. You should not stop taking any medication without first consulting your physician.